Individualized accelerated isotoxic concurrent chemo-radiotherapy for stage III non-small cell lung cancer: 5-Year results of a prospective study

Dirk De Ruysscher; Angela van Baardwijk; Rinus Wanders; Lizza E. Hendriks; Bart Reymen; Wouter van Empt; Michel C. Ollers; Gerben Bootsma; Cordula Pitz; Linda van Eijsden; Anne-Marie C. Dingemans

doi:10.1016/j.radonc.2019.03.009

Individualized accelerated isotoxic concurrent chemo-radiotherapy for stage III non-small cell lung cancer: 5-Year results of a prospective study

Dirk De Ruysscher^*, Angela van Baardwijk, Rinus Wanders, Lizza E. Hendriks, Bart Reymen, Wouter van Empt, Michel C. Ollers, Gerben Bootsma, Cordula Pitz, Linda van Eijsden, Anne-Marie C. Dingemans

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

36 Downloads (Pure)

Original language	English
Pages (from-to)	141-146
Number of pages	6
Journal	Radiotherapy and Oncology
Volume	135
DOIs	https://doi.org/10.1016/j.radonc.2019.03.009
Publication status	Published - Jun 2019

Keywords

Non-small cell lung cancer
Individualized radiotherapy
Concurrent chemotherapy radiotherapy
Phase II trial
Prospective
NORMAL TISSUE CONSTRAINTS
LOCALLY ADVANCED HEAD
LONG-TERM SURVIVAL
RADIATION-THERAPY
PHASE-III
DOSE-ESCALATION
RADIOTHERAPY
CHEMOTHERAPY
TRIAL
CISPLATIN

Access to Document

10.1016/j.radonc.2019.03.009

Full TextFinal published version, 656 KBLicence: Taverne

Cite this

De Ruysscher, D., van Baardwijk, A., Wanders, R., Hendriks, L. E., Reymen, B., van Empt, W., Ollers, M. C., Bootsma, G., Pitz, C., van Eijsden, L., & Dingemans, A-M. C. (2019). Individualized accelerated isotoxic concurrent chemo-radiotherapy for stage III non-small cell lung cancer: 5-Year results of a prospective study. Radiotherapy and Oncology, 135, 141-146. https://doi.org/10.1016/j.radonc.2019.03.009

De Ruysscher, Dirk ; van Baardwijk, Angela ; Wanders, Rinus ; Hendriks, Lizza E. ; Reymen, Bart ; van Empt, Wouter ; Ollers, Michel C. ; Bootsma, Gerben ; Pitz, Cordula ; van Eijsden, Linda ; Dingemans, Anne-Marie C. / Individualized accelerated isotoxic concurrent chemo-radiotherapy for stage III non-small cell lung cancer : 5-Year results of a prospective study. In: Radiotherapy and Oncology. 2019 ; Vol. 135. pp. 141-146.

@article{4febcb93703045728e61890435cd162c,

title = "Individualized accelerated isotoxic concurrent chemo-radiotherapy for stage III non-small cell lung cancer: 5-Year results of a prospective study",

keywords = "Non-small cell lung cancer, Individualized radiotherapy, Concurrent chemotherapy radiotherapy, Phase II trial, Prospective, NORMAL TISSUE CONSTRAINTS, LOCALLY ADVANCED HEAD, LONG-TERM SURVIVAL, RADIATION-THERAPY, PHASE-III, DOSE-ESCALATION, RADIOTHERAPY, CHEMOTHERAPY, TRIAL, CISPLATIN",

author = "{De Ruysscher}, Dirk and {van Baardwijk}, Angela and Rinus Wanders and Hendriks, {Lizza E.} and Bart Reymen and {van Empt}, Wouter and Ollers, {Michel C.} and Gerben Bootsma and Cordula Pitz and {van Eijsden}, Linda and Dingemans, {Anne-Marie C.}",

year = "2019",

month = jun,

doi = "10.1016/j.radonc.2019.03.009",

language = "English",

volume = "135",

pages = "141--146",

journal = "Radiotherapy and Oncology",

issn = "0167-8140",

publisher = "Elsevier Ireland Ltd",

}

De Ruysscher, D , van Baardwijk, A, Wanders, R, Hendriks, LE , Reymen, B , van Empt, W, Ollers, MC, Bootsma, G, Pitz, C, van Eijsden, L & Dingemans, A-MC 2019, 'Individualized accelerated isotoxic concurrent chemo-radiotherapy for stage III non-small cell lung cancer: 5-Year results of a prospective study', Radiotherapy and Oncology, vol. 135, pp. 141-146. https://doi.org/10.1016/j.radonc.2019.03.009

Individualized accelerated isotoxic concurrent chemo-radiotherapy for stage III non-small cell lung cancer : 5-Year results of a prospective study. / De Ruysscher, Dirk ; van Baardwijk, Angela; Wanders, Rinus; Hendriks, Lizza E.; Reymen, Bart ; van Empt, Wouter; Ollers, Michel C.; Bootsma, Gerben; Pitz, Cordula; van Eijsden, Linda; Dingemans, Anne-Marie C.

In: Radiotherapy and Oncology, Vol. 135, 06.2019, p. 141-146.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Individualized accelerated isotoxic concurrent chemo-radiotherapy for stage III non-small cell lung cancer

T2 - 5-Year results of a prospective study

AU - De Ruysscher, Dirk

AU - van Baardwijk, Angela

AU - Wanders, Rinus

AU - Hendriks, Lizza E.

AU - Reymen, Bart

AU - van Empt, Wouter

AU - Ollers, Michel C.

AU - Bootsma, Gerben

AU - Pitz, Cordula

AU - van Eijsden, Linda

AU - Dingemans, Anne-Marie C.

PY - 2019/6

Y1 - 2019/6

KW - Non-small cell lung cancer

KW - Individualized radiotherapy

KW - Concurrent chemotherapy radiotherapy

KW - Phase II trial

KW - Prospective

KW - NORMAL TISSUE CONSTRAINTS

KW - LOCALLY ADVANCED HEAD

KW - LONG-TERM SURVIVAL

KW - RADIATION-THERAPY

KW - PHASE-III

KW - DOSE-ESCALATION

KW - RADIOTHERAPY

KW - CHEMOTHERAPY

KW - TRIAL

KW - CISPLATIN

U2 - 10.1016/j.radonc.2019.03.009

DO - 10.1016/j.radonc.2019.03.009

M3 - Article

C2 - 31015160

VL - 135

SP - 141

EP - 146

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

SN - 0167-8140

ER -